Chemical Structure (Figure 01)
Levamlodipine
Product Images NDC 42195-425
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levamlodipine (NDC 42195-425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Xspire Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (2.5 mg Tablet Bottle Label)
Each tablet contains 25mg of evariodipine (equivalent to 3.2mg of levamlodipine maleate). The recommended dosage is from 15°C to 50°C (55°F to 86°F), and this package is designed to be stored at 20°C to 25°C (68°F to 77°F). Levamlodipine Tablets should be dispensed in tight, light-resistant containers. Protect from light. This package is from CSPC Ouy Phamasessea Co. Ltd., Shijiazhuang, Hebe, China, and it contains 30 tablets. This information is accurate as of the last revision, dated 08/2021. Only available by prescription.*
Principal Display Panel (5 mg Tablet Bottle Label)
The description is: "Each pack of tablets contain 30 tablets of Evamiocipine, with each tablet consisting of 5 mg. The package is designed to be child-resistant and should be stored at 3 to 20°C. The lot number is Xspire and the tablets can only be obtained with a prescription (Rx only)."*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
